CTLA4 and neoplasm: The reversal of the exhausted T cell phenotype by CTLA-4/PD-1 blockade is thought to promote T cell mediated killing of tumor cells via T cell recognition of neoantigens that are unique to the tumor cells, and which arise from tumor cell- specific gene mutations.